CRIS Current Research Information System

AMBROSINI, VALENTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.272
AS - Asia 10.861
EU - Europa 8.247
SA - Sud America 699
AF - Africa 554
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 3
Totale 31.647
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.121
VN - Vietnam 3.334
SG - Singapore 2.742
CN - Cina 2.702
GB - Regno Unito 2.008
DE - Germania 1.265
NL - Olanda 1.103
IT - Italia 957
HK - Hong Kong 717
SE - Svezia 639
FR - Francia 502
BR - Brasile 501
IN - India 469
RU - Federazione Russa 420
UA - Ucraina 368
IE - Irlanda 267
ZA - Sudafrica 189
JP - Giappone 172
KR - Corea 155
FI - Finlandia 149
EE - Estonia 119
BD - Bangladesh 116
CI - Costa d'Avorio 112
CH - Svizzera 106
TG - Togo 97
AR - Argentina 85
CA - Canada 71
SC - Seychelles 66
PH - Filippine 65
AT - Austria 60
ES - Italia 53
JO - Giordania 53
BG - Bulgaria 48
ID - Indonesia 47
IQ - Iraq 46
MX - Messico 45
TR - Turchia 44
BE - Belgio 41
NG - Nigeria 39
TH - Thailandia 39
PL - Polonia 36
IR - Iran 27
GR - Grecia 26
CO - Colombia 24
EC - Ecuador 24
PY - Paraguay 21
TW - Taiwan 21
PK - Pakistan 20
HR - Croazia 19
CL - Cile 15
LT - Lituania 14
UZ - Uzbekistan 14
MA - Marocco 13
MY - Malesia 13
SA - Arabia Saudita 12
VE - Venezuela 10
AU - Australia 9
CZ - Repubblica Ceca 9
EG - Egitto 9
LB - Libano 9
IL - Israele 7
JM - Giamaica 7
PA - Panama 7
PE - Perù 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
RO - Romania 6
BO - Bolivia 5
CR - Costa Rica 5
MD - Moldavia 5
TN - Tunisia 5
UY - Uruguay 5
AL - Albania 4
BJ - Benin 4
CY - Cipro 4
DK - Danimarca 4
KE - Kenya 4
NP - Nepal 4
OM - Oman 4
TT - Trinidad e Tobago 4
DZ - Algeria 3
HU - Ungheria 3
KG - Kirghizistan 3
KZ - Kazakistan 3
MU - Mauritius 3
NO - Norvegia 3
PT - Portogallo 3
RS - Serbia 3
SM - San Marino 3
AO - Angola 2
AZ - Azerbaigian 2
ET - Etiopia 2
EU - Europa 2
KW - Kuwait 2
NI - Nicaragua 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BB - Barbados 1
Totale 31.627
Salva come PNG Salva come JPEG
Città #
Singapore 1.860
Southend 1.798
Fairfield 1.160
Ashburn 1.073
Chandler 735
Hong Kong 681
Kerkrade 648
Ho Chi Minh City 617
San Jose 566
Woodbridge 544
Hanoi 518
Houston 518
Seattle 512
Wilmington 479
Princeton 407
Frankfurt am Main 391
Cambridge 384
Dong Ket 384
Beijing 366
Santa Clara 344
Eygelshoven 338
Ann Arbor 276
Hefei 274
Dublin 268
Boardman 261
Lauterbourg 218
Jacksonville 217
Bologna 187
Los Angeles 175
Nanjing 169
Westminster 160
Padova 144
Tokyo 139
Seoul 130
Council Bluffs 128
Helsinki 124
New York 121
Abidjan 112
Berlin 111
Dallas 105
Buffalo 99
Lomé 97
Bern 96
Jinan 93
Shenyang 90
Da Nang 88
Haiphong 84
Milan 79
Guangzhou 78
Saint Petersburg 76
Hebei 66
São Paulo 66
Changsha 65
Redondo Beach 65
Redmond 62
Shanghai 59
Tianjin 58
Medford 57
Amman 53
Chicago 53
San Diego 52
Mülheim 51
Johannesburg 50
Nanchang 50
Turin 48
Zhengzhou 45
Bremen 44
Munich 40
Sofia 40
Abeokuta 35
Phoenix 35
Vienna 34
Dearborn 33
Brussels 32
Des Moines 32
Jiaxing 32
Nuremberg 32
Bengaluru 31
Hangzhou 31
Redwood City 30
Yubileyny 30
Florence 28
Falkenstein 27
Rome 27
Wuhan 27
Biên Hòa 26
Can Tho 26
Thái Nguyên 26
San Francisco 25
Falls Church 24
Haikou 24
London 24
Mahé 23
Montreal 23
Orem 23
Quận Bình Thạnh 23
Columbus 21
Shenzhen 21
Tongling 21
Baghdad 20
Totale 20.392
Salva come PNG Salva come JPEG
Nome #
18F-FDG PET/CT in visceral leishmaniasis: uptake patterns in the context of a multiannual outbreak in Northern Italy 1.738
Merkel cell carcinoma: a prompt diagnosis to increase survival 660
68Ga-DOTATATE PET/CT interobserver agreement for neuroendocrine tumor assessment: Results of a prospective study on 50 patients 337
Radiomic analysis performed on 68Ga-DOTANOC PET/CT allows discriminating primary pancreatic neuroendocrine tumour grading 299
A [68Ga]Ga-DOTANOC PET/CT radiomic model for non-invasive prediction of tumour grade in pancreatic neuroendocrine tumours 270
F-18 FDG PET/CT detects muscle involvement in Erdheim-Chester disease 269
(18)F-FDG PET/CT diagnosis of unexpected extracardiac septic embolisms in patients with suspected cardiac endocarditis. 258
18F-FDG-PET/CT imaging in cardiac tumors: illustrative clinical cases and review of the literature. 246
Comparing PET-derived semiquantitative parameters and radiomic features in discriminating G1 and G2 primary pancreatic neuroendocrine tumours in 68Ga-DOTANOC PET/CT 237
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 227
18F-FACBC Compared With 11C-Choline PET/CT in Patients With Biochemical Relapse After Radical Prostatectomy: A Prospective Study in 28 Patients. 225
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 225
Antitumor Activity of Sustained N-Myc Reduction in Rhabdomyosarcomas and Transcriptional Block by Antigene Therapy 225
Biliary stone disease in patients receiving somatostatin analogs for neuroendocrine neoplasms. A retrospective observational study 222
68Ga-DOTANOC PET/CT Detects Multifocal Hepatocellular Carcinoma 222
18F-FDG PET in mucosa-associated lymphoid tissue (MALT) lymphoma. 217
Is surgery the best treatment for sporadic small (≤2 cm) non-functioning pancreatic neuroendocrine tumours? A single centre experience 213
(11)C-Choline PET/CT in patients with hormone-resistant prostate cancer showing biochemical relapse after radical prostatectomy. 210
Successful multidisciplinary clinical approach and molecular characterization by whole transcriptome sequencing of a cardiac myxofibrosarcoma: A case report 209
11C-choline vs. 18F-FDG PET/CT in assessing bone involvement in patients with multiple myeloma. 208
Consensus on molecular imaging and theranostics in neuroendocrine neoplasms 208
18F-FDG PET/CT for the Assessment of Disease Extension and Activity in Patients With Sarcoidosis: Results of a Preliminary Prospective Study 205
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 204
Role of [18F]Fluorodeoxyglucose Positron Emission Tomography Scan in the Follow-Up of Lymphoma 203
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 201
68Ga-labelled peptides for diagnosis of gastroenteropancreatic NET. 196
Discordant response to chemotherapy: An unusual pattern of fluoro-deoxy-D-glucose uptake in heavily pre-treated lymphoma patients 195
18f-fdg pet/ct for restaging gastric cancer after surgical resection 195
Radiomic analysis could allow detecting misassigned bioptic grading when discriminating G1 and G2 primary pancreatic neuroendocrine tumours imaged with 68Ga-DOTANOC PET/CT 193
11C-Choline PET/CT in patients with biochemical relapse after radical prostatectomy and PSA levels < 0.5 ng/mL 191
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 190
18F-FDG PET/CT detects systemic involvement in Sarcoidosis 190
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 188
Liver metastases from prostate cancer at 11C-Choline PET/CT: a multicenter, retrospective analysis 188
G1/G2 discrimination of pNET with [68Ga]Ga-DOTANOC PET/CT quantitative parameters: is it feasible? 188
New PET Radiotracers for the Imaging of Neuroendocrine Neoplasms 186
Assessment of a chemically induced model of lung squamous cell carcinoma in mice by 18F-FDG small-animal PET. 185
Incidental diagnosis of very small rectal neuroendocrine neoplasms: when should endoscopic submucosal dissection be performed? A single ENETS centre experience 185
A cure model survival analysis of patients affected by small intestinal neuroendocrine neoplasms: the Bologna ENETS center experience 185
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 184
18F-FLT PET/CT in patients with advanced Non-Small Lung Cancer (NSCLC) treated with Nivolumab: preliminary results 184
68Ga-DOTA-NOC PET/CT detects somatostatin receptors expression in von hippel-lindau cerebellar disease. 183
TÉCNICAS DE MEDICINA NUCLEAR EN LA VALORACIÓN DE LOS TUMORES NEUROENDOCRINOS 183
Radionuclide Theranostics in Neuroendocrine Neoplasms: An Update 181
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 175
Colon Sarcoidosis Mimicking Cancer at 18F-FDG PET/CT 175
Additional value of hybrid PET/CT fusion imaging vs. conventional CT scan alone in the staging and management of patients with malignant pleural mesothelioma 174
The Role of mTOR in Neuroendocrine Tumors: Future Cornerstone of a Winning Strategy? 174
Treatment of advanced gastro‐entero‐pancreatic neuro‐ endocrine tumors: A systematic review and network meta‐analysis of phase iii randomized controlled trials 174
Analisi in vitro ed in vivo dell'attività anti-tumorale dopo inibizione specifica di MYCN mediante PNA-NLS anti-gene nel rabdomiosarcoma umano 172
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 171
Preliminary evaluation of 68Ga-DOTA-NOC PET/CT in patients with idiopathic pulmonary fibrosis 171
68Ga-DOTA-NOC: a new PET tracer for evaluating patients with bronchial carcinoid. 171
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 171
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for colorectal neuroendocrine tumours 170
Real-Life Use of [68Ga]Ga-DOTANOC PET/CT in Confirmed and Suspected NETs from a Prospective 5-Year Electronic Archive at an ENETS Center of Excellence: More Than 2000 Scans in More Than 1500 Patients 169
[68Ga]Ga-DOTANOC Uptake at Pancreatic Head/Uncinate Process: Is It a Persistent Diagnostic Pitfall Over Time? 169
Comparison between 18F-FDG PET/CT and 11C-Choline PET/CT for the evaluation of multiple myeloma 168
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 168
Is radical surgery always curative in pancreatic neuroendocrine tumors? A cure model survival analysis 168
Case Report: The Complete Remission of a Mixed Germ Cell Tumor With Somatic Type Malignancy of Sarcoma Type With a GCT-Oriented Therapy: Clinical Findings and Genomic Profiling 166
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 164
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 164
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 163
68Ga DOTANOC PET/CT Detects Primary Malignant Insulinoma. 163
111In-pentetreotide scintigraphy: procedure guidelines for tumour imaging. 162
Validation of the 2010 WHO classification and a new prognostic proposal: A single centre retrospective study of well-differentiated pancreatic neuroendocrine tumours 160
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 160
Focal lung uptake of 18F-fluorodeoxyglucose (18F-FDG) without computed tomography findings. 159
FDG small animal PET permits early detection of malignant cells in a xenograft murine model. 158
Retro-orbital injection is an effective route for radiopharmaceutical administration in mice during small-animal PET studies. 156
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 156
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 156
Procedure guidelines for PET/CT tumour imaging with 68Ga-DOTA-conjugated peptides: 68Ga-DOTA-TOC, 68Ga-DOTA-NOC, 68Ga-DOTA-TATE. 155
Standardized uptake values of (68)Ga-DOTANOC PET: a promising prognostic tool in neuroendocrine tumors. 154
Role of PET/CT and Therapy Management of Pancreatic Neuroendocrine Tumors 154
Histopathological diagnosis of appendiceal neuroendocrine neoplasms: when to perform a right hemicolectomy? A systematic review and meta-analysis 153
Preliminary results of the Italian FOLCETUX study: early evaluation of treatment response with 18FDG PET in gastric or gastroesophageal junction adenocarcinoma. 152
Radiomic Model Discriminating Low Grade Pancreatic Neuroendocrine Tumours Assessed by Biopsy of the Primary Lesion 151
Advancements in Neuroendocrine Neoplasms: Imaging and Future Frontiers 150
Osteoblastic bone response mimicking bone progression during treatment with pembrolizumab in advanced cutaneous melanoma 148
Performance evaluation of a small animal PET scanner. Spatial resolution characterization using F-18 and C-11. 146
Comparison of Different Positron Emission Tomography Tracers in Patients with Recurrent Medullary Thyroid Carcinoma: Our Experience and a Review of the Literature 145
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 145
[68Ga]Ga-DOTANOC PETICT & radiomics: Potential role in discriminating tumor grade in well-differentiated primary pancreatic neuroendocrine tumors 145
A new dimension of FDG-PET interpretation: assessment of tumor biology. 144
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 144
Pitfalls in oncology: Osteoblastic response mimicking bone progression during ceritinib treatment in ALK-rearranged NSCLC 144
18[F]FDG small animal PET study of sorafenib efficacy in lymphoma preclinical models. 144
Small animal PET for the evaluation of an animal model of genital infection 144
Two birds with one stone: can [68Ga]Ga-DOTANOC PET/CT image quality be improved through BMI-adjusted injected activity without increasing acquisition times? 143
FDG-PET in the serial assessment of patinets with lymphoma in complete remission 143
Usefulness of FDG-PET in detection of local and distant recurrent cervical cancer in symptomatic women 143
Metachronous solitary metastasis to the thyroid gland from squamous cell carcinoma of the lung: a case report and literature review 143
18F-FDG PET/CT impact on testicular tumours clinical management 142
Is there an ideal diagnostic algorithm in solitary pulmonary nodules? 140
Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients 140
Sporadic Small (≤20 mm) Nonfunctioning Pancreatic Neuroendocrine Neoplasm: is the Risk of Malignancy Negligible When Adopting a More Conservative Strategy? A Systematic Review and Meta-analysis 140
[68Ga]Ga-DOTANOC PET/CT Derived Radiomic Features Can Discriminate Pancreatic Neuroendocrine Tumours from Accessory Spleens: Preliminary Results 140
Detection of unknown primary neuroendocrine tumours (CUP-NET) using (68)Ga-DOTA-NOC receptor PET/CT. 138
Totale 20.065
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.747
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.747
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021779 0 0 0 0 0 0 0 0 0 0 0 779
2021/20223.781 846 112 204 222 298 178 55 252 140 138 818 518
2022/20233.481 385 509 207 435 211 245 100 183 563 189 265 189
2023/2024885 96 159 40 77 72 167 53 56 34 61 35 35
2024/20254.052 144 648 350 254 626 210 512 94 48 191 199 776
2025/202611.488 755 1.313 874 722 1.086 1.540 1.331 450 1.974 807 383 253
Totale 32.145